Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. This cancer develops slowly, with no early detectable symptoms for many years. The precise cause of prostate cancer is unknown; however, factors such as obesity, high calcium diet, lack of exercise, ethnicity (African American men), and old age contribute to its occurrence.
In 2018, the global Prostate Cancer Medicine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Prostate Cancer Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostate Cancer Medicine development in United States, Europe and China.
The key players covered in this study
Teva Pharmaceuticals Industries Ltd.
Johnson & Johnson
Astellas Pharma Inc.
Roche Holding AG
Market segment by Type, the product can be split into
Pipeline Drugs for Hormonal Therapy
Market segment by Application, split into
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Prostate Cancer Medicine status, future forecast, growth opportunity, key market and key players.
To present the Prostate Cancer Medicine development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Prostate Cancer Medicine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.